<DOC>
	<DOC>NCT00567775</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to compare the pharmacokinetic profile of two different methods of insulin administration in children with type 1 diabetes.</brief_summary>
	<brief_title>Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes Treatment for at least 12 months HbA1c lesser or equal to 11.0% Body weight between 25 and 80 Kg Capable to use the device Any diseases other than diabetes requiring prescriptive medication Known or suspected allergy to trial product or related products Active proliferative retinopathy as judged by the Investigator Recurrent severe hypoglycaemia as judged by the Investigator The receipt of any investigational drug within 4 weeks prior to this trial</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>